Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0ISNZK
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Her3-C3-ADC-23 (DAR4)
|
|||||
| Synonyms |
Her3 C3 ADC 23 (DAR4)
Click to Show/Hide
|
|||||
| Organization |
Suzhou Medilink Therapeutics Ltd.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 2 Indication(s)
Colon cancer [ICD11:2B90]
Investigative
Lung cancer [ICD11:2C25]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
4.9
|
|||||
| Structure |
|
|||||
| Antibody Name |
Her3-C3
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-3 (ERBB3)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Her3-C3-ADC-23(DAR4) linker
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.